🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Treatment of Metastatic Breast Cancer is not usually considered curative. R...
Status
Unknown
Location
Tehran University of Medical Sciences
Start Date
2020-11-20
Trial ID
NCT04697043
Treatments Being Tested
The correlation between the values of angiogenesis-related growth factors i...
Status
Completed
Location
EPS Corporation
Start Date
2013-05
Trial ID
NCT01834014
Most of HLA-A2 melanomas express Melan-A/MART-1 antigen and are recognized ...
Status
Completed
Location
Nantes University Hopspital
Start Date
2000-11
Trial ID
NCT00720031
Treatments Being Tested
The primary objective of this study is to evaluate the safety, efficacy, an...
Status
Completed
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2020-10-30
Trial ID
NCT07504484
Treatments Being Tested
This phase IIa study is designed to evaluate the safety and efficacy of mul...
Status
Completed
Location
Cliniques Universitaires Saint-Luc
Start Date
2020-07-01
Trial ID
NCT04405349
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, cisplatin, oxa...
Status
Completed
Location
Centre Hospitalier General
Start Date
2005-10
Trial ID
NCT00304135
Treatments Being Tested
The purpose of this study was to estimate the response rate of ixabepilone ...
Status
Completed
Location
Local Institution
Start Date
2008-06
Trial ID
NCT00633464
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin, gemcitabine, and ...
Status
Terminated
Location
Hollings Cancer Center at Medical University of South Carolina
Start Date
2005-09-21
Trial ID
NCT00268450
Treatments Being Tested
Primary objective: To evaluate the efficacy of two different dosing schedul...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00185302
In order to improve and individualize cancer treatment, personalized treatm...
Status
Unknown
Location
Per Sandström
Start Date
2022-05-17
Trial ID
NCT05289076
Treatments Being Tested